Identity Management Challenges in Pharma & Biotech SaaS Platforms (And How to Solve Them)

Pharmaceutical and biotech companies are increasingly adopting SaaS platforms for drug discovery, clinical development, and commercialization, necessitating robust identity and access management (IAM) strategies to manage sensitive data and diverse user populations. As the life sciences software market grows, driven by advancements like AI in drug discovery and applications of quantum computing, the need for precise access control, traceability, and accountability becomes critical. Companies face challenges like regulatory compliance, protecting intellectual property, and managing complex user bases, which require dynamic solutions such as attribute-based access control and centralized identity governance. By integrating cloud-native, API-driven IAM platforms, organizations can enhance security and compliance while facilitating collaboration and innovation. Effective identity management not only safeguards data but also offers a competitive edge by enabling scalable and auditable access across rapidly evolving digital ecosystems.